Skip to main content
. 2021 May 18;2021(5):CD007579. doi: 10.1002/14651858.CD007579.pub3

Tarhan 2007.

Study characteristics
Methods RCT
Participants 88 ASA 1‐2, 20‐38 year old women undergoing elective CS under spinal anaesthesia with no history of GI disease, recent antiemetic use or contraindication for regional anaesthesia.
Interventions Intervention 1: sedative (Comparison 6)
  • Propofol 20 mg bolus, 1 mg/kg/hour.

  • N = 30.


Intervention 2: sedative (Comparison 6)
  • Midazolam 1 mg bolus 1 mg/kg/hour.

  • N = 30.


Comparison: placebo
  • Normal saline.

  • N = 28.

Outcomes Nausea, vomiting, retching ‐ intraoperative and postoperative.
Notes Setting: Ankara, Turkey.
Dates: not reported.
Funding source: not reported.
Declaration of interest: not reported.
Retching combined with vomiting. In Table 2, Column 4, reports that the control group consisted of n = 28, but then in the body of the table, it states n = 30. Email correspondence with author confirms that 28 participants were actually enrolled in the control group.
Drugs are in separate subgroups but then pooled in our analysis so the placebo data are dealt with according to our methods (Unit of analysis issues)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated random number list.
Allocation concealment (selection bias) Low risk Drugs prepared and covered according to a random number list by a personnel member who was not aware of the study.
Blinding of participants and personnel (performance bias)
All outcomes Low risk Quote: "Double blind". No additional information about participant blinding.
Blinding of outcome assessment (detection bias)
All outcomes Low risk Postoperative outcomes assessed by blinded clinician.
Incomplete outcome data (attrition bias)
All outcomes Low risk None.
Selective reporting (reporting bias) Unclear risk We did not assess the trial protocol.
Other bias Low risk No baseline differences.